Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12860940 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Erlotinib

Indicates status has not been verified in more than two years